Hostname: page-component-cb9f654ff-fg9bn Total loading time: 0 Render date: 2025-08-08T18:00:55.520Z Has data issue: false hasContentIssue false
  • English
  • Français

Economic analysis of endobronchial ultrasound (EBUS) as a tool in the diagnosis and staging of lung cancer in Singapore

Published online by Cambridge University Press:  15 April 2010

Shin Yuh Ang ,
Rachel Woo Yin Tan ,
Mariko Siyue Koh  and
Jeremy Lim
Shin Yuh Ang
Affiliation:
Singapore Health Services Pte Ltd.
Rachel Woo Yin Tan
Affiliation:
Jurong General Hospital
Mariko Siyue Koh
Affiliation:
Singapore General Hospital
Jeremy Lim
Affiliation:
Singapore Health Services Pte Ltd.
Get access Rights & Permissions [Opens in a new window]

Abstract

Objectives: Endobronchial ultrasound (EBUS), encompassing endobronchial ultrasound transbronchial needle aspiration (EBUS-TBNA) and Endobronchial ultrasound transbronchial lung biopsy (EBUS-TBLB) has been proven to be a useful modality in the staging and diagnosis of lung cancer. However, there are limited publications on the cost-effectiveness of EBUS and no economic evaluations relevant to the Singapore setting. An economic evaluation using our hospital's data was used to assess the cost implications of EBUS substituting where clinically appropriate: transthoracic needle aspiration; (TTNA), fluoroscopy-guided transbronchial lung biopsy (TBLB), and mediastinoscopy in the diagnosis and staging of lung cancer.

Methods: Relationship between the clinical and economic implications of alternative modalities was modeled using data inputs that were relevant to the Singapore setting. Two decision analytic models were constructed to evaluate the cost of EBUS compared with TTNA, TBLB, and staging mediastinoscopy. Only direct costs were imputed.

Results: In the base–case analysis, TTNA was the most economical strategy (SGD3,335 = US$2,403) where clinically suitable for the diagnosis of lung cancer as compared to the other options: TBLB (SGD4,499) and EBUS-TBLB (SGD4,857). On the other hand, EBUS-TBNA resulted in expected cost savings of SGD1,214 per positive staging of lung cancer as compared to mediastinoscopy.

Conclusions: The use of EBUS-TBNA could result in cost savings of SGD1,214 per positive staging of lung cancer as compared to mediastinoscopy. Whereas TTNA was the most economical intervention for the diagnosis of lung cancer as compared to the other options, its main limitation lies in its suitability only for peripheral lung lesions and high complication rate.

Keywords

Lung neoplasmsHealth economicsUltrasonography

Information

Type
ASSESSMENTS
Information
International Journal of Technology Assessment in Health Care , Volume 26 , Issue 2 , April 2010 , pp. 170 - 174
Copyright
Copyright © Cambridge University Press 2010

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

REFERENCES

1. American College of Chest Physician (ACCP). Diagnosis and management of lung cancer: American College of Chest Physician (ACCP) Guidelines. 2nd ed. Chest 2007. 2007;132 (Suppl):1S–422S.Google Scholar
2. Eloubeidi, MA, Tamhane, A, Chen, VK, et al. Endoscopic ultrasound-guided fine-needle aspiration in patients with non-small cell lung cancer and prior negative mediastinoscopy. The Soc Thorac Surg. 2005;80:1231–1240.Google Scholar
3. Harewood, GC, Wiersema, MJ, Edell, ES, et al. Cost-minimization analysis of alternative diagnostic approaches in a modeled patient with non-small cell lung cancer and subcarinal lymphadenopathy. Mayo Clin Proc. 2002;77:155–164.CrossRefGoogle Scholar
4. Herth, FJF, Eberhardt, R, Vilmann, P, et al. Real-time endobronchial ultrasound guided transbronchial needle aspiration for sampling mediastinal lymph nodes. Thorax. 2006;61:795–798.Google Scholar
5. Herth, FJF, Ernst, A, Becker, HD. Endobronchial ultrasound-guided transbronchial lung biopsy in solitary pulmonary nodules and peripheral lesions. Eur Respir J. 2002;20:972–974.Google Scholar
6. Koh, MS, Tee, A, Wong, P, Antippa, P et al. , Advances in lung cancer diagnosis and staging: Endobronchial ultrasound. Intern Med J. 2007.Google Scholar
7. Kramer, H, Putten, JWG, Post, WJ, et al. Oesphageal endoscopic ultrasound with fine needle aspiration improves and simplifies the staging of lung cancer. Thorax. 2004;59:596–601.Google Scholar
8. Medical Services Advisory Committee. Endoscopic ultrasound guided fine-needle aspiration for the staging of non-cell lung cancer and the diagnosis of mediastinal masses. Commonwealth of Australia. 2007.Google Scholar
9. Singapore Cancer Registry, 2006. Singapore Cancer Registry Interim Report. Trends in cancer incidence in Singapore 2002-2006. [Online] (Updated 2006). http://www.hpb.gov.sg/uploadedFiles/HPB_Online/Publications/CancerTrends2002-2006.pdf (accessed May 25, 2009).Google Scholar
Supplementary material: File

Ang et al. supplementary material

Supplementary figures

Download Ang et al. supplementary material(File)
File 1.2 MB